Pages that link to "Q40081805"
Jump to navigation
Jump to search
The following pages link to Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector. (Q40081805):
Displaying 13 items.
- Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritis (Q36052152) (← links)
- Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies (Q36238764) (← links)
- Lentiviral vectors for immune cells targeting (Q37677792) (← links)
- Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy (Q37782256) (← links)
- Physiological and tissue-specific vectors for treatment of inherited diseases (Q37801839) (← links)
- Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression (Q37981217) (← links)
- Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter (Q39033552) (← links)
- A simple and rapid nonviral approach to efficiently transfect primary tissue-derived cells using polyethylenimine (Q39361963) (← links)
- Viral gene therapy for breast cancer: progress and challenges (Q39366114) (← links)
- Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38. (Q39434928) (← links)
- Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. (Q40005186) (← links)
- Regulated expression of murine CD40L by a lentiviral vector transcriptionally targeted through its endogenous promoter (Q41533331) (← links)
- Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins (Q96303609) (← links)